Clovis Oncology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2020 to Q3 2022
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Clovis Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q3 2022.
- Clovis Oncology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 145M shares, a 19.3% increase year-over-year.
- Clovis Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 116M shares, a 37% increase from 2020.
- Clovis Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 84.3M shares, a 56.5% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)